Security is crucial for pharmaceutical and healthcare organisations in an environment that is becoming more and more digital. Strong security measures are needed to protect intellectual property and sensitive data. Fortunately, a number of cybersecurity companies have distinguished themselves as forerunners in harnessing artificial intelligence (AI) to protect data in the pharmaceutical and healthcare industries. In this article, we showcase five of these companies that are at the forefront of developing cutting-edge cybersecurity solutions that are driven by artificial intelligence.
SecureShield integrates artificial intelligence (AI) techniques and machine learning to provide sophisticated threat detection and prevention solutions. Their cutting-edge technology continuously monitors network traffic, endpoints, and data access points in real-time to identify and neutralise any cyber attacks. The AI-driven strategy of SecureShield improves proactive threat prevention, protecting the protection of critical healthcare and pharmaceutical data.
CipherGuard specialises in artificial intelligence-powered data encryption and access control systems. Their sophisticated algorithms encrypt critical data at rest and in transit, providing strong protection against unauthorised access. CipherGuard uses artificial intelligence to dynamically alter access privileges based on user behaviour, guaranteeing that only authorised persons can access and manipulate important healthcare and pharmaceutical data.
Noventiq (the brand name of Cyprus-registered Softline Holding plc) is a global solutions and services provider in digital transformation and cybersecurity, which has been headquartered and listed in London. The company enables, facilitates and accelerates digital transformation for its customers’ businesses. Noventiq’s AI solutions help in securing sensitive data to protect patient confidentiality.
Sentinix employs artificial intelligence-based behavioural analytics to identify potential insider threats within healthcare and pharmaceutical organisations. Their cybersecurity system examines user actions, access patterns, and data consumption to detect unusual behaviour that could signal unauthorised access or data exfiltration. The continuous monitoring and AI-driven anomaly detection capabilities of Sentinix improve data security by proactively identifying and mitigating potential insider threats.
ShieldCyber specializes in AI-enhanced endpoint security solutions for healthcare and pharma environments. Their cybersecurity solution utilizes AI algorithms to monitor and protect all endpoints, including devices and applications, from potential cyber threats. ShieldCyber’s AI-driven anomaly detection and behavioral analysis capabilities enable the detection and mitigation of endpoint-related security risks, safeguarding critical healthcare and pharma systems and data.